Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|February 7, 2025
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM studyChristina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Rheumatology and Therapy|July 5, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM StudyRohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Arthritis Research & Therapy|January 17, 2024
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM studyRohit Aggarwal, Joachim Schessl, Christina Charles-Schoeman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2008
Role of GluR1 in activity-dependent motor system developmentLei Zhang, Joachim Schessl, Markus Werner, et al.
The Journal of Cell Biology|December 17, 2008
Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathyBelinda S Cowling, Meagan J McGrath, Mai-Anh Nguyen, et al.
Orphanet Journal of Rare Diseases|February 15, 2013
Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trialMaggie C Walter, Peter Reilich, Simone Thiele, et al.
Biochemical and Biophysical Research Communications|April 14, 2015
In vivo characterization of human myofibrillar myopathy genes in zebrafishJohn B Bührdel, Sofia Hirth, Mirjam Kessler, et al.
The Lancet. Neurology|August 31, 2010
Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trialJanbernd Kirschner, Joachim Schessl, Ulrike Schara, et al.
Journal of Neuropathology and Experimental Neurology|August 23, 2013
Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disordersEdoardo Malfatti, Montse Olivé, Ana Lía Taratuto, et al.
The Journal of Clinical Investigation|February 16, 2008
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathyJoachim Schessl, Yaqun Zou, Meagan J McGrath, et al.
Pageof 4